TNF and glioblastoma: IFN-DCs from glioblastoma patients were characterized by more than a twofold decrease in TNFα mRNA levels in comparison with donor IFN-DCs (Me 2−ΔΔCt = 0.35; p = 0.05; Figure 4a).